Report Detail

Request for Sample of this report

Pharma & Healthcare Global Biologics and Biosimilars Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2930156
    • |
  • 09 January, 2020
    • |
  • Global
    • |
  • 139 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Summary

Market Overview
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019.
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biologics and Biosimilars market has been segmented into Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other, etc.
By Application, Biologics and Biosimilars has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Biologics and Biosimilars market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Biologics and Biosimilars markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biologics and Biosimilars are: Roche, Eli Lilly, Sanofi-Aventis, Amgen, Novo Nordisk, AbbVie, Merck, Pfizer, Johnson & Johnson, Novartis, Gelgen, Ganlee, 3sbio, Innovent, Biotech, Changchun High Tech, Dong Bao, CP Guojian, etc. Among other players domestic and global, Biologics and Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2018 and 2019.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Biologics and Biosimilars Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Monoclonal Antibodies
      • 1.2.3 Interferon
      • 1.2.4 Erythropoietin
      • 1.2.5 Insulin
      • 1.2.6 Vaccines
      • 1.2.7 Other
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Tumor
      • 1.3.3 Diabetes
      • 1.3.4 Cardiovascular
      • 1.3.5 Hemophilia
      • 1.3.6 Other
    • 1.4 Overview of Global Biologics and Biosimilars Market
      • 1.4.1 Global Biologics and Biosimilars Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Roche Details
      • 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Roche SWOT Analysis
      • 2.1.4 Roche Product and Services
      • 2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Eli Lilly
      • 2.2.1 Eli Lilly Details
      • 2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Eli Lilly SWOT Analysis
      • 2.2.4 Eli Lilly Product and Services
      • 2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Sanofi-Aventis
      • 2.3.1 Sanofi-Aventis Details
      • 2.3.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Sanofi-Aventis SWOT Analysis
      • 2.3.4 Sanofi-Aventis Product and Services
      • 2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Amgen
      • 2.4.1 Amgen Details
      • 2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Amgen SWOT Analysis
      • 2.4.4 Amgen Product and Services
      • 2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Novo Nordisk
      • 2.5.1 Novo Nordisk Details
      • 2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Novo Nordisk SWOT Analysis
      • 2.5.4 Novo Nordisk Product and Services
      • 2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 AbbVie
      • 2.6.1 AbbVie Details
      • 2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 AbbVie SWOT Analysis
      • 2.6.4 AbbVie Product and Services
      • 2.6.5 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Merck
      • 2.7.1 Merck Details
      • 2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Merck SWOT Analysis
      • 2.7.4 Merck Product and Services
      • 2.7.5 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Pfizer
      • 2.8.1 Pfizer Details
      • 2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Pfizer SWOT Analysis
      • 2.8.4 Pfizer Product and Services
      • 2.8.5 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Johnson & Johnson
      • 2.9.1 Johnson & Johnson Details
      • 2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Johnson & Johnson SWOT Analysis
      • 2.9.4 Johnson & Johnson Product and Services
      • 2.9.5 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Novartis
      • 2.10.1 Novartis Details
      • 2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Novartis SWOT Analysis
      • 2.10.4 Novartis Product and Services
      • 2.10.5 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Gelgen
      • 2.11.1 Gelgen Details
      • 2.11.2 Gelgen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Gelgen SWOT Analysis
      • 2.11.4 Gelgen Product and Services
      • 2.11.5 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Ganlee
      • 2.12.1 Ganlee Details
      • 2.12.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Ganlee SWOT Analysis
      • 2.12.4 Ganlee Product and Services
      • 2.12.5 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 3sbio
      • 2.13.1 3sbio Details
      • 2.13.2 3sbio Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 3sbio SWOT Analysis
      • 2.13.4 3sbio Product and Services
      • 2.13.5 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Innovent
      • 2.14.1 Innovent Details
      • 2.14.2 Innovent Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Innovent SWOT Analysis
      • 2.14.4 Innovent Product and Services
      • 2.14.5 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Biotech
      • 2.15.1 Biotech Details
      • 2.15.2 Biotech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Biotech SWOT Analysis
      • 2.15.4 Biotech Product and Services
      • 2.15.5 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 Changchun High Tech
      • 2.16.1 Changchun High Tech Details
      • 2.16.2 Changchun High Tech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 Changchun High Tech SWOT Analysis
      • 2.16.4 Changchun High Tech Product and Services
      • 2.16.5 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.17 Dong Bao
      • 2.17.1 Dong Bao Details
      • 2.17.2 Dong Bao Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.17.3 Dong Bao SWOT Analysis
      • 2.17.4 Dong Bao Product and Services
      • 2.17.5 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.18 CP Guojian
      • 2.18.1 CP Guojian Details
      • 2.18.2 CP Guojian Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.18.3 CP Guojian SWOT Analysis
      • 2.18.4 CP Guojian Product and Services
      • 2.18.5 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 4.5 South America Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country
      • 5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 6.3 UK Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 6.4 France Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 7.5 India Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 7.7 Australia Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country
      • 8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020)
    • 10.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Biologics and Biosimilars Price by Type (2015-2020)

    11 Global Biologics and Biosimilars Market Segment by Application

    • 11.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
    • 11.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
    • 11.3 Global Biologics and Biosimilars Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Biologics and Biosimilars Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Biologics and Biosimilars Market Forecast (2021-2025)
      • 12.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2025)
      • 12.2.4 South America Biologics and Biosimilars Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2025)
    • 12.3 Biologics and Biosimilars Market Forecast by Type (2021-2025)
      • 12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025)
    • 12.4 Biologics and Biosimilars Market Forecast by Application (2021-2025)
      • 12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Biologics and Biosimilars . Industry analysis & Market Report on Biologics and Biosimilars is a syndicated market report, published as Global Biologics and Biosimilars Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Biologics and Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,232.92
      		4,849.38
      		6,465.84
      		532,196.40
      		798,294.60
      		1,064,392.80
      		290,301.60
      		435,452.40
      		580,603.20
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo